Newron Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.4%.

Top 18 shareholders own 12.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.22%	Gefim S.p.A.	785,448	CHF5.3m	0%	no data
4.03%	Heights Capital Management, Inc.	750,000	CHF5.0m	0%	3.27%
1.34%	Credit Suisse Asset Management (Switzerland) Ltd.	249,488	CHF1.7m	3.71%	no data
0.94%	UBS Asset Management AG	175,514	CHF1.2m	14.1%	no data
0.62%	ZKB Asset Management	114,600	CHF766.7k	0%	no data
0.54%	Zürcher Kantonalbank, Investment Arm	99,850	CHF668.0k	0%	0.01%
0.22%	Ravi Anand	41,872	CHF280.1k	0%	no data
0.22%	Ulrich Köstlin	40,249	CHF269.3k	0%	no data
0.19%	BlackRock, Inc.	36,106	CHF241.6k	9.84%	no data
0.18%	Pictet Asset Management Limited	32,760	CHF219.2k	0%	no data
0.13%	Wyss & Partner AG	25,000	CHF167.3k	0%	0.4%
0.13%	Lombard Odier Asset Management (Switzerland) SA	24,039	CHF160.8k	35.5%	0.01%
0.11%	Stefan Weber	20,351	CHF136.2k	0%	no data
0.064%	Patrick Langlois	12,000	CHF80.3k	140%	no data
0.019%	Migrosbank Asset Management	3,619	CHF24.2k	0%	no data
0.013%	Roberto Galli	2,500	CHF16.7k	0%	no data
0.013%	State Street Global Advisors, Inc.	2,463	CHF16.5k	0%	no data
0.0079%	LLB Asset Management AG	1,477	CHF9.9k	0%	no data